Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Market Cap

USD 18.06 B

Share Price

USD 91.28

Avg Daily Volume

2,352,833

Change (1 day)

-2.12%

Change (1 year)

-14.67%

Change (YTD)

-13.58%

Zimmer Biomet Holdings, Inc. Price to Book Ratio (P/B) on June 13, 2025: 1.45

Zimmer Biomet Holdings, Inc. Price to Book Ratio (P/B) is 1.45 on June 13, 2025, a -16.42% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Zimmer Biomet Holdings, Inc. 52-week low Price to Book Ratio (P/B) is 1.87 on June 13, 2025, which is 29.32% above the current Price to Book Ratio (P/B).
  • Zimmer Biomet Holdings, Inc. 52-week low Price to Book Ratio (P/B) is 1.43 on June 13, 2025, which is -0.88% below the current Price to Book Ratio (P/B).
  • Zimmer Biomet Holdings, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 1.69.
Key data
Date Price to Book Ratio (P/B) Price to Sales Ratio (P/S) Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield
Market news
Loading...
NYSE: ZBH

Zimmer Biomet Holdings, Inc.

CEO Mr. Ivan Tornos
IPO Date July 25, 2001
Location United States
Headquarters 345 East Main Street
Employees 17,000
Sector 🏥 Health Care
Industries
Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Similar companies

GKOS

Glaukos Corporation

USD 97.60

0.00%

OFIX

Orthofix Medical Inc.

USD 11.00

-1.43%

BIO

Bio-Rad Laboratories, Inc.

USD 226.91

-2.37%

BRKR

Bruker Corporation

USD 38.30

-3.94%

SRDX

Surmodics, Inc.

USD 29.16

0.27%

CNMD

CONMED Corporation

USD 53.55

-2.58%

CVRX

CVRx, Inc.

USD 5.86

-1.18%

EW

Edwards Lifesciences Corporation

USD 75.15

-0.97%

SYK

Stryker Corporation

USD 377.30

-0.84%

ABT

Abbott Laboratories

USD 135.62

-0.61%

MDT

Medtronic plc

USD 87.27

-1.38%

ITGR

Integer Holdings Corporation

USD 118.30

-0.38%

LUNG

Pulmonx Corporation

USD 3.03

-3.50%

BSX

Boston Scientific Corporation

USD 99.74

1.20%

StockViz Staff

June 16, 2025

Any question? Send us an email